Gene Query: CTDSPL2

Dataset Description Geneva Score
Human cell line and subcutaneous tumor 26.16
Transcriptomic analysis of LSD1 25.53
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 23.66
Tracing Enhancer Networks using Epigenetic Traits (TENET) 21.6
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 21.42
ETV7 and interferon response 20.88
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 20.88
RNA expression analysis upon JMJD1C depletion 20.18
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 20.18
Biological effect of chronic mistranslation in mammalian cells 20.11
Human HAP1 cells before and after nutrient deprivation 17.25
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 17.25
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 16.66
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 16.45
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 16.27
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.23
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 16.23
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 15.65
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 14.99
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 14.87
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 14.76
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 14.7
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 14.63
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 14.5
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 14.26
RIG-I and MDA5 fRIP during KSHV lytic reactivation 14.04
Proteolytic cleavage by taspase1 and the regulation of the stability of MLL1 13.74
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 13.57
AR-independent prostate cancer is sustained through FGF signaling 13.56
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 13.25
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 12.33
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 12.31
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 12.31
Cleavage Factor Im as a key regulator of 3’ UTR length 12.04
LncRNA expression profiling of ischemic stroke patients 11.98
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 11.98
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 11.72
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 11.53
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 11.27
Expression by CD133+ cells isolated from the adult human exocrine pancreas 11.15
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 10.96
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 10.81
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 10.78
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 10.73
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 10.73
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 10.69
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 10.61
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 10.38
SUV420H2 knockdown in PANC-1 10.37
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 10.06
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 10.03
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 10.0
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 9.87
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 9.82
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 9.72
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 9.71
Electronic cigarettes 9.7
Transcriptome analysis of U87 cells upon LINC00152 knockdown 9.67
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.66
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 9.63
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 9.48
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 9.3
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 9.24
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 9.22
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 9.12
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 9.1
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 9.07
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 8.98
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 8.93
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 8.91
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 8.88
RNAseq Study in CC-671 Treated Cal-51 Cells 8.86
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 8.84
N6-methyladenine DNA Modification in Glioblastoma 8.83
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 8.83
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 8.74
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 8.74
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.64
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 8.63
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 8.61
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 8.59
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 8.59
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 8.52
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 8.46
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 8.35
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 8.29
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 8.29
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 8.28
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 8.2
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.12
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.11
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 8.03
Targeting MTHFD2 in Acute Myeloid Leukemia 8.01
Rorc disruption in human FG pancreatic cancer cells 7.97
K562 polyA RNA-Seq 7.88
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 7.82
Developmental stage specific chromosome architecture in human erythroid cells 7.82
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 7.82
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 7.78
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 7.74
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 7.69
Effect of PBK knockdown on C4-2 cell transcriptome 7.67
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 7.64
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 7.63
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.59
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 7.55
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 7.53
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 7.51
RNA-seq analysis to identify the genes regulated by p53-SET interplay 7.48
3’ Uridylation Expands miRNA Target Repertoire 7.48
Functional role of SLIT2 and ROBO1 in trophoblasts 7.47
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 7.39
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 7.36
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 7.34
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 7.29
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 7.28
Altering cancer transcriptomes using epigenomic inhibitors 7.28
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 7.28
Impact of dieldrin on transcription in Jurkat T cells 7.27
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 7.26
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 7.23
R430: A potent inbibitor of DNA and RNA viruses 7.22
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 7.22
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.17
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 7.17
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 7.17
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 7.15
SLAM-seq for K562 endogenous mRNA decay 7.08
NHLRC1 re-expression in cancer cells 7.06
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.06
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 7.03
Global Mapping of Human RNA-RNA Interactions 7.0
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 6.98
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 6.98
Nucleoporin-mediated regulation of cell identity genes 6.97
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.91
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.91
Ribosomal footprinting of CN34-Parental and CN34-LM1a 6.88
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 6.87
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 6.85
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.84
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.83
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.83
Single-cell analysis of human kidney organoids 6.82
Transcriptomic analysis of ERR alpha orphan nuclear receptor 6.81
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.79
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.79
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.72
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 6.67
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 6.65
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 6.6
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 6.56
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.55
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 6.54
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 6.54
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 6.53
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 6.53
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 6.52
RNA sequencing of BT142 and TS603 cell lines 6.52
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 6.51
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 6.49
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 6.49
Ribosomal footprinting of MDA-Parental and MDA-LM2 6.47
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.42
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 6.4
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 6.39
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 6.38
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 6.38
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.38
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 6.38
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 6.38
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 6.36
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 6.36
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 6.35
The pioneer factor CEBPA modulates vitamin D signaling 6.35
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 6.34
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.29
Induced DNA demethylation, genome instability and transcription 6.27
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 6.27
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 6.26
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 6.26
nELAVL HITS-CLIP in Alzheimer's Disease patients 6.24
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 6.24
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 6.23
Transcriptome analysis of BAP1 knockout and restoration 6.23
FBXW7 modulates stress response by post-translational modification of HSF1 6.23
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 6.23
Chromatin-informed inference of transcriptional programs in gynecologic cancers 6.19
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 6.19
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 6.16
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 6.15
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.13
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 6.12
Tyrosine Kinase Inhibitor Cardiotoxicity 6.11
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 6.11
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 6.06
Transcriptome analysis in Neobractatin treated cells 6.06
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 6.04
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 6.02
Transcriptome-wide response to synthetic chromatin protein PcTF 6.0
Regulation of poly(A) tail and translation during the somatic cell cycle 6.0
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.98
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 5.85
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 5.81
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 5.78
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 5.78
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.76
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.74
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 5.7
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 5.7
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 5.68
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 5.67
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.64
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 5.64
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 5.64
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.63
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 5.61
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 5.59
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 5.56
TT-Seq captures the human transient transcriptome 5.53
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 5.53
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.52
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 5.5
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 5.49
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 5.41
DAOY-Notch1/Notch2 knockout: transcriptome comparison 5.4
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 5.39
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 5.37
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 5.37
Differentiation enhances Zika virus infection in neuronal brain cells 5.36
Cranial pericytes derived from neural crest cells reveal an inherent cell type-specific defect in Alzheimer's Disease 5.35
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.3
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 5.3
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.29
The Genetic Landscape of Diamond-Blackfan Anemia 5.29
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.26
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.26
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 5.26
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.23
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 5.21
Genes significantly down or Up-regulated upon RNF219 knockdown 5.19
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 5.18
Unique features and clinical importance of acute alloreactive immune responses 5.16
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 5.16
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 5.15
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 5.13
TGF-β regulation of miRNA expression in pancreatic cancer 5.09
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 5.05
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 5.05
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 5.0
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.0
UV_24h_GRO-Seq 4.95
LncRNA-GAS5 negative regulation of YAP-target genes expression 4.94
Systematic discovery of endogenous human ribonucleoprotein complexes 4.9
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.89
Capturing the Interactome of Newly Transcribed RNA 4.89
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 4.85
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 4.85
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 4.78
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 4.75
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.74
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.68
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.67
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process (RNA-seq) 4.67
Cockayne syndrome A and B proteins regulate the transcription arrest upon genotoxic stress through a ubiquitin/proteasome degradation process 4.67
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 4.66
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 4.66
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 4.64
PTHrP overexpression in MCF7 cells 4.62
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 4.62
PRDM1 inhibits proliferation of human colon cancer organoids 4.54
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.5
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 4.48
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 4.45
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 4.44
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 4.43
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 4.43
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.42
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.36
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.34
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.34
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 4.32
Effect of PRDM11 depletion in U2932 cells 4.32
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.32
Generation of KRAS signatures using immortalized isogenic lung cells. 4.29
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 4.29
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 4.25
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 4.25
Transcriptome sequencing of K-562 cells 4.24
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.16
Mapping interactions for the TNIP2 hub protein 4.15
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 4.14
A code of mono-phosphorylation modulates the function of RB. 4.1
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 4.07
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 4.05
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.05
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.05
Real-time observation of light-controlled transcription in living cells 4.01
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 4.0
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 3.98
Regulation of protein translation during mitosis 3.95
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.95
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 3.94
The contribution of Alu exons to the human proteome 3.92
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 3.9
EWS-Fli and LNC regulated genes in comparison to GFP samples 3.89
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.89
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 3.88
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 3.88
mRNA recovered upon RNF219 IP. [RNA-IP] 3.81
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.8
RNA-seq of RKO cells with cTAZ KO or putback 3.78
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 3.75
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 3.74
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.71
Identification of global XBP1s target gene expression in human prostate cancer cells 3.68
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 3.67
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 3.66
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 3.63
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.63
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 3.57
Noncoding regions are the main source of targetable tumor-specific antigens 3.56
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 3.56
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 3.56
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.53
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.52
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.41
The cohesin release factor WAPL restricts chromatin loop extension. 3.41
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 3.4
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 3.4
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 3.37
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 3.37
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 3.35
Functional role of CPPED1 in trophoblasts. 3.31
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.31
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.31
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 3.3
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 3.3
EWSR1 influences alternative splicing through direct and indirect mechanisms 3.3
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 3.26
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 3.25
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 3.23
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 3.23
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 3.19
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 3.18
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 3.16
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 3.16
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 3.13
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 3.13
Mechanistic Model-Guided Study of Embryonic Morphogenesis 3.09
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 3.06
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.06
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 3.05
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 3.04
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 3.04
RNA polymerase in pre-B-ALL cell lines 3.04
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 2.93
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.84
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.76
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.71
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 2.66
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 2.63
RNA sequencing with KSHV infection and enrichment for circular RNAs 2.63
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.62
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.61
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.57
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.54
m6A-dependent regulation of messenger RNA stability 2.54
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.53
Microprocessor mediates transcription termination in long noncoding microRNA genes 2.53
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 2.53
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 2.5
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.46
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.42
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.42
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.42
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 2.38
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.38
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.38
O-glcnAc reprograms cellular energetics 2.36
Genetic-to-epigenetic Therapy for Pancreatic Cancer 2.36
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.34
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.33
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.33
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.23
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 2.22
Effect of drugs on transcriptomic profiles 2.21
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 2.19
Gene expression profiling of leukemia cells following asparagine depletion 2.18
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 2.15
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.12
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 2.11
mRNA-Seq profiling of human developing kidney 2.04
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.02
RNA-Seq of PRMT1 overexpression ECA109 cells 1.96
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.95
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.95
RNA-seq analysis of control and Myc-induced U2OS cells 1.95
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.88
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.88
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.88
Disruption of the exocyst induces podocyte loss and dysfunction 1.84
RNA-Seq from human ILC transitional populations 1.82
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.82
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 1.79
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 1.78
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 1.69
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 1.69
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 1.65
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.57
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.57
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 1.56
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 1.55
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.54
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.53
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.53
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.51
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.5
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.5
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 1.47
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 1.47
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.43
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.43
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 1.42
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 1.4
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 1.35
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.33
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 1.23
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 1.22
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.16
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.15
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.14
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.07
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 1.02
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.97
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 0.93
HBEC-shp53-PCHD7 0.93
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.9
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.9
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.89
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.89
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.89
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.88
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 0.86
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 0.86
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.84
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.8
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.8
Gene expressions of H9s in different culture systems 0.76
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.74
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.7
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.68
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.66
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.63
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.6
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 0.6
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.59
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.55
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.54
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.54
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.53
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 0.51
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.45
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.45
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.43
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.4
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.35
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.35
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 0.34
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.33
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.3
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.3
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.3
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 0.29
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 0.28
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 0.27
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.21
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.21
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.19
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.18
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.16
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.15
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.15
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 0.14
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 0.14
Transcriptome-wide modulation of splicing by the exon junction complex 0.13
Aging-associated patterns in the expression of human endogenous retroviruses 0.1
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 0.1
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.1
RNA-seq of primary patient AML samples 0.09
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.08
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.08
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.08
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.08
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.07
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.07
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.05
Modulation of nonsense-mediated decay by rapamycin 0.05
BACH2 in human plasma cell fate decision 0.0
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation